1.Rex, A, Schickert, R, Fink, H.Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test rats. Pharmacol Biochem Behav 2004;77:303–307.
2.Murray, CJL. The global burden of disease. In: Murray, CJ, Lopez, AD, eds. Global burden of disease and injury series. Boston, MA: The Harvard School of Public Health, 1996.
3.Shelton, RC.The molecular neurobiology of depression. Psychiatric Clin North Am 2007;30:1–11.
4.Kessler, RC, Gonagle, KA, Zhao, S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8–19.
5.Kessler, RC, Rubinow, DR, Holmes, C, Abelson, JM, Zhao, S.The epidemiology of DSM-III-R bipolar disorder in a general population survey. Psychol Med 1997;27: 1079–1089.
6.Longone, P, Rupprecht, R, Manieri, GA, Bernardi, G, Romeo, E, Pasini, A.The complex roles of neurosteroids in depression and anxiety disorders. Neurochem Int 2008;52: 596–601.
7.Mico, JA, Ardid, D, Berrocoso, E, Eschalier, A.Antidepressants and pain. Trends Pharmacol Sci 2006;7:348–354.
8.Stahl, SM, Pradko, JF, Haight, BR, Modell, JB, Rockett, CB, Learned-Coughlin, S.A review of the neuropharmacology of bupropion, a dual norepinephrin and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 2004;6:159–166.
9.Duman, RS, Nakagawa, S, Malberg, J.Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 2001;25:836–844.
10.Jacobs, BL, Praag, H, Gage, FH.Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 2000;5:262–269.
11.Heales, SJ, Bolaños, JP, Stewart, VC, Brookes, PS, Land, JM, Clark, JB.Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1999;1410:215–228.
12.Blass, JP.Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia? J Neurosci Res 2001;66:851–856.
13.Schurr, A.Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia. Neurochem Int 2002;41:1–8.
14.Madrigal, JL, Olivenza, R, Moro, MA et al. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 2001;24:420–429.
15.Boekema, EJ, Braun, HP.Supramolecular structure of the mitochondrial oxidative phosphorylation system. J Chem Biol 2007;282:1–4.
16.Kelly, D, Gordon, J, Alpers, R et al. The tissue-specific expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins. Medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase. J Biol Chem 1989;264:18921–18925.
17.Corrêa, C, Amboni, G, Assis, LC et al. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:887–891.
18.Tyler, D.The mitochondrion in health and diseases. New York: VCH Publishers, 1992.
19.Brennan, WA, Bird, ED, Aprille, JR.Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem 1985;44:1948.
20.Heales, SJ, Bolanõs, JP, Stewart, VC, Brookes, PS, Land, JM, Clark, JB.Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1999;1410:215–228.
21.Schurr, A.Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia. Neurochem Int 2002;41:1–8.
22.Monsalve, M, Borniquel, S, Valle, I, Lamas, S.Mitochondrial dysfunction in human pathologies. Front Biosci 2007;12:1131–1153.
23.Moreira, PI, Santos, MS, Oliveira, CR.Alzheimer's disease: a lesson from mitochondrial dysfunction. Antioxid Redox Signal 2007;9:1621–1630.
24.Moreira, PI, Santos, MS, Seiça, R, Oliveira, CR.Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes. J Neurol Sci 2007;257:206–214.
25.Bessman, SP, Carpenter, CL.The Creatine-Creatine phosphate energy shuttle. Annu Rev Biochem 1985;54:831–865.
26.Wallimann, T, Wyss, M, Brdiczka, D, Nicolay, K, Eppenberger, HM.Intracellular compartmentation, structure and function of Creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphoCreatine circuit' for cellular energy homeostasis. Biochem J 1992;281: 21–40.
27.Streck, EL, Amboni, G, Scaini, G et al. Brain creatine kinase activity in an animal model of mania. Life Sci 2008; 82:424–429.
28.Burigo, M, Roza, CA, Bassani, C et al. Decreased Creatine kinase activity caused by electroconvulsive shock. Neurochem Res 2006;31:877–881.
29.Kanarick, M, Matrov, D, Kõiv, K, Eller, M, Tõnissaar, M, Harro, J.Changes in regional long-term oxidative metabolism induced by partial serotonergic denervation and chronic variable stress in rat brain. Neurochem Int 2008;52: 432–437.
30.Stanyer, L, Jorgensen, W, Hori, O, Clark, JB, Heales, SJ.Inactivation of brain mitochondrial Lon protease by peroxynitrite precedes electron transport chain dysfunction. Neurochem Int 2008;53:95–101.
31.Kitamira, Y, Fujitani, Y, Kitagawa, K et al. Effects of imipramine and bupropion on the duration of immobility of acth-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA. Biol Pharm Bull 2008;31:246–249.
32.Lowry, OH, Rosebough, NG, Farr, AL et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265–275.
33.Shepherd, D, Garland, PB.The kinetic properties of citrate synthase from rat liver mitochondria. Biochem J 1969;114:597–610.
34.Kitto, GB.Intra- and extramitochondrial malate dehydrogenases from chicken and tuna heart. Meth Enzymol 1969;XIII:106–116.
35.Fischer, JC, Ruitenbeek, W, Berden, JA et al. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 1985;153:23–26.
36.Cassina, A, Radi, R.Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996;328:309–316.
37.Rustin, P, Chretien, D, Bourgeron, T et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994;228:35–51.
38.Hughes, BP.A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathologic sera. Clin Chim Acta 1962;7:597–604.
39.Arnaiz, SL, Coronel, MF, Boveris, A.Nitric oxide, superoxide and hydrogen peroxide production in brain mitochondria after haloperidol treatment. Nitric Oxide 1999;3: 235–243.
40.Adam-Vizi, V.Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal 2005;7:1140–1149.
41.Assis, LC, Rezin, GT, Comim, CM et al. Effect of acute administration of ketamine and imipramine on creatine kinase activity in the brain of rats. Rev Bras Psiquiatr 2009; 31:247–252.
42.Scaini, G, Santos, PM, Benedet, J et al. Evaluation of krebs cycle enzymes in the brain of rats after chronic administration of antidepressants. Brain Res Bull 2010;52: 224–227.
43.Gardner, A, Johansson, A, Wibom, R et al. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J Affect Dis 2003;76:55–68.
44.Madrigal, JL, Olivenza, R, Moro, MA et al. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 2001;24:420–429.
45.Rezin, GT, Cardoso, MR, Gonçalves, CL et al. Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochem Int 2008;53:395–400.
46.Wellman, PJ.Modulation of eating by central catecholamine systems. Curr Drug Targets 2005;6:191–199.
47.Ascher, JA, Cole, JO, Colin, JN et al. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995;56:395–401.
48.Stahl, SM, Pradko, JF, Haight, BR, Modell, JG, Rockett, CB, Learned-Coughlin, S.A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 2004;6:159–166.
49.Scaini, G, Maggi, DD, De-Nês, BT et al. Activity of mitochondrial respiratory chain is increased by chronic administration of antidepressants. Acta Neuropsychiatrica 2011; 23:112–118.
50.Santos, PM, Scaini, G, Rezin, GT et al. Brain creatine kinase activity is increased by chronic administration of paroxetine. Brain Res Bull 2009;80:327–330.
51.Agostinho, FR, Scaini, G, Ferreira, GK et al. Effects of olanzapine, fluoxetine and olanzapine/fluoxetine on creatine kinase activity in rat brain. Brain Res Bull 2009;80: 337–340.